Works matching IS 00316970 AND DT 2022 AND VI 78 AND IP 1

Results: 20

Sports nutrition supplements and adverse events – a meta-epidemiological study of case reports specifically addressing causality assessment.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 1, doi. 10.1007/s00228-021-03223-9

By:

Zeijlon, Rickard;
Hantelius, Victor;
Wallerstedt, Susanna M.;
Holmqvist, Lina

Publication type:

Article

To establish a model for the prediction of initial standard and maintenance doses of warfarin for the Han Chinese population based on gene polymorphism: a multicenter study.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 43, doi. 10.1007/s00228-021-03146-5

By:

Xia, Xiaotong;
Huang, Nianxu;
Li, Boxia;
Li, Yan;
Zou, Lang;
Yuan, Dongdong;
Huang, Banghua;
Bei, Yufei;
Liu, Yuxin;
Fu, Jinglan;
Wu, Tingting;
Chen, Wenjun;
Jiang, Shaojun;
Lv, Meina;
Zhang, Jinhua

Publication type:

Article

Restrictions on the use of placebo in new COVID-19 vaccine trials.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 147, doi. 10.1007/s00228-021-03203-z

By:

Bonati, Maurizio

Publication type:

Article

Proton pump inhibitors and osteoporosis risk: exploring the role of TRPM7 channel.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 35, doi. 10.1007/s00228-021-03237-3

By:

Desai, Bhargavi V.;
Qadri, Misbah N.;
Vyas, Bhavin A.

Publication type:

Article

Correction to: Population pharmacokinetics‑pharmacodynamics of fondaparinux in dialysis‑dependent chronic kidney disease patients undergoing chronic renal replacement therapy.

Published in:

2022

By:

Michaličková, Danica;
Hartinger, Jan Miroslav;
Hladinová, Zuzana;
Bednářová, Vladimíra;
Szonowská, Barbora;
Polakovič, Vladimír;
Matthios, Andreas;
Tesař, Vladimír;
Slanař, Ondřej;
Krekels, Elke H. J.

Publication type:

Correction Notice

Intravenous lidocaine vs. NSAIDs for migraine attack in the ED: a prospective, randomized, double-blind study.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 27, doi. 10.1007/s00228-021-03219-5

By:

Gur, Sultan Tuna Akgol;
Ahiskalioglu, Elif Oral;
Aydin, Muhammed Enes;
Kocak, Abdullah Osman;
Aydin, Pelin;
Ahiskalioglu, Ali

Publication type:

Article

The impact of PIPs on mortality and readmissions in older adults: a retrospective cohort study.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 139, doi. 10.1007/s00228-021-03217-7

By:

Pardo-Cabello, Alfredo Jose;
Manzano-Gamero, Victoria;
Luna, Juan de Dios

Publication type:

Article

Low- vs high-dose ARNI effects on clinical status, exercise performance and cardiac function in real-life HFrEF patients.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 19, doi. 10.1007/s00228-021-03210-0

By:

Corrado, Egle;
Dattilo, Giuseppe;
Coppola, Giuseppe;
Morabito, Claudia;
Bonni, Enrico;
Zappia, Luca;
Novo, Giuseppina;
de Gregorio, Cesare

Publication type:

Article

Correction to: Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment.

Published in:

2022

By:

Watanabe, Akiko;
Ishizuka, Tomoko;
Yamada, Makiko;
Igawa, Yoshiyuki;
Shimizu, Takako;
Ishizuka, Hitoshi

Publication type:

Correction Notice

Evaluation of pharmacogenomics and hepatic nuclear imaging–related covariates by population pharmacokinetic models of irinotecan and its metabolites.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 53, doi. 10.1007/s00228-021-03206-w

By:

Liu, Zheng;
Martin, Jennifer H.;
Liauw, Winston;
McLachlan, Sue-Anne;
Link, Emma;
Matera, Anetta;
Thompson, Michael;
Jefford, Michael;
Hicks, Rod J.;
Cullinane, Carleen;
Hatzimihalis, Athena;
Campbell, Ian;
Crowley, Simone;
Beale, Phillip J.;
Karapetis, Christos S.;
Price, Timothy;
Burge, Mathew E.;
Michael, Michael

Publication type:

Article

Improving medication adherence and effective prescribing through a patient-centered prescription model in patients with multimorbidity.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 127, doi. 10.1007/s00228-021-03207-9

By:

González-Bueno, J.;
Sevilla-Sánchez, D.;
Puigoriol-Juvanteny, E.;
Molist-Brunet, N.;
Codina-Jané, C.;
Espaulella-Panicot, J.

Publication type:

Article

CYP2D6 genetic variation in Ugandans.

Published in:

2022

By:

Miura, Jun;
Obua, Celestino;
Abbo, Catherine;
Tateishi, Tomonori;
Kaneko, Sunao

Publication type:

Letter to the Editor

Delayed crises following benzodiazepine withdrawal: deficient adaptive mechanisms or simple pharmacokinetics? Detoxification assisted by serum-benzodiazepine elimination tracking.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 101, doi. 10.1007/s00228-021-03205-x

By:

Basińska-Szafrańska, Anna

Publication type:

Article

European NSTEMI guidelines—return of clopidogrel?

Published in:

2022

By:

Dannenberg, Lisa;
M'Pembele, René;
Metzen, Daniel;
Petzold, Tobias;
Zeus, Tobias;
Kelm, Malte;
Polzin, Amin

Publication type:

Letter

Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 65, doi. 10.1007/s00228-021-03194-x

By:

Watanabe, Akiko;
Ishizuka, Tomoko;
Yamada, Makiko;
Igawa, Yoshiyuki;
Shimizu, Takako;
Ishizuka, Hitoshi

Publication type:

Article

Response/comments to maternal paracetamol intake and fetal ductus arteriosus closure: adding pieces to the scenery—Karel Allegaert, Michael Ceulemans, John van den Anke.

Published in:

2022

By:

Hauben, Manfred;
Bai, Stephen;
Hung, Eric;
Lobello, Kasia;
Tressler, Charles;
Zucal, Vincent P.

Publication type:

Letter to the Editor

The effect of potent CYP2D6 inhibition on the pharmacokinetics and safety of deutetrabenazine in healthy volunteers.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 11, doi. 10.1007/s00228-021-03202-0

By:

Schneider, F.;
Stamler, D.;
Bradbury, M. J.;
Loupe, P. S.;
Gordon, M. F.;
Rabinovich-Guilatt, L.

Publication type:

Article

Population pharmacokinetics-pharmacodynamics of fondaparinux in dialysis-dependent chronic kidney disease patients undergoing chronic renal replacement therapy.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 89, doi. 10.1007/s00228-021-03201-1

By:

Michaličková, Danica;
Hartinger, Jan Miroslav;
Hladinová, Zuzana;
Bednářová, Vladimíra;
Szonowská, Barbora;
Polakovič, Vladimír;
Matthios, Andreas;
Tesař, Vladimír;
Slanař, Ondřej;
Krekels, Elke H. J.

Publication type:

Article

Impacts of cachexia progression in addition to serum IgG and blood lymphocytes on serum nivolumab in advanced cancer patients.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 77, doi. 10.1007/s00228-021-03199-6

By:

Abe, Kazuki;
Shibata, Kaito;
Naito, Takafumi;
Otsuka, Atsushi;
Karayama, Masato;
Maekawa, Masato;
Miyake, Hideaki;
Suda, Takafumi;
Kawakami, Junichi

Publication type:

Article

Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 111, doi. 10.1007/s00228-021-03196-9

By:

Borovac, Josip A.;
Leth-Olsen, Mette;
Kumric, Marko;
D'Amario, Domenico;
Schwarz, Konstantin;
Glavas, Duska;
Bozic, Josko

Publication type:

Article